Ironwood Pharmaceuticals Announces Intent to Separate Soluble Guanylate Cyclase (sGC) Business from Commercial and Gastrointestinal Business
Go back to Ironwood Pharmaceuticals Announces Intent to Separate Soluble Guanylate Cyclase (sGC) Business from Commercial and Gastrointestinal Business| IRONWOOD PHARMA-A (NASDAQ: IRWD) | Delayed: 3.86 +0.04 (1.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.82 | 52 Week High | $16.89 | |||
| Open | $3.77 | 52 Week Low | $7.35 | |||
| Day High | $3.92 | P/E | N/A | |||
| Day Low | $3.76 | EPS | $-2.35 | |||
| Volume | 1,444,966 | |||||
